Endocrinology
Conference Coverage
Cardiovascular risks elevated in transgender youth
A multicenter study shows increased risk for some cardiovascular and metabolic outcomes. The causes are not well understood.
Conference Coverage
Hyperphagia, anxiety eased with carbetocin in patients with Prader-Willi syndrome
From the Journals
Cardiovascular disease remains leading cause of type 2 diabetes mortality
Lab values topped clinical variables in predicting all-cause death among a high-risk population.
News
FDA okays new indication for alirocumab in homozygous FH
The FDA approved use of the PCSK9 inhibitor as an add-on therapy in adults with rare homozygous familial hypercholesterolemia.
From the Journals
Use of complimentary and alternative medicine common in diabetes patients
Roughly half of diabetes patients may be using complementary and alternative medicine, but most don’t tell their healthcare providers.
Pearl of the Month
Artifactual hypoglycemia: When there’s a problem in the tube
A patient has labs that don’t make sense clinically.
Conference Coverage
Combo thyroid hormones as good as levothyroxine for hypothyroidism
In a randomized, double-blind study of three common approaches to hypothyroidism, no significant differences in symptoms were reported.
Conference Coverage
Metyrapone for Cushing’s syndrome: Safe, effective in first test
Conference Coverage
PCOS equivalent in men: No ovaries required
From the Journals
Women with PCOS at increased risk for COVID-19
Women with PCOS may fear an increased infection risk "will further compromise timely access to health care and serve to increase the sense of...
From the Journals
Diabetes prevention moves toward reality as studies published
Newly published 3-year data on teplizumab in high-risk individuals and combination therapy with liraglutide in new-onset type 1 diabetes show...